Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome
Psycho-Oncology, 04/24/2012
Aspinwall LG et al. – Among US participants familiar with their hereditary melanoma risk through prior epidemiological research participation, CDKN2A/p16 genetic testing provides multiple perceived benefits to both carriers and noncarriers without inducing distress in general or worry about melanoma or pancreatic cancer.



